DUBLIN–(BUSINESS WIRE)–The “Global Western Blotting Market 2019-2027” report has been added to ResearchAndMarkets.com’s offering.
Global western blotting market is expected to display an upward trend while growing with 4.87% of CAGR in the forecast years 2019-2027. Western blotting or protein immunoblotting is a broadly used analytical technique used in immunogenetics and molecular biology for detecting specific proteins in a given sample.
The growing incidences of HIV and Lyme disease are driving the growth of the western blotting market globally. Even though tests such as ELISA, polymerase chain reaction (PCR), indirect fluorescent antibody (IFA) are used to detect HIV, the probability of inaccurate results using these tests is very high. On the other hand, western blotting can effectively distinguish between HIV antibodies and other antibodies to provide accurate results.
Therefore, more doctors and experts recommend western blotting tests due to the accuracy and reliability they offer, and this will drive market growth during the forecast period. Lyme disease is a tick-transmitted bacterial infection, which is becoming increasingly prevalent of late. The accurate diagnosis of Lyme disease is critical to ensure that the patients suffering from the condition are given appropriate antibiotics. The growing uncertainty towards the treatment has increased the usage of western blot technique for the detection of Lyme disease.
The western blot technique is widely used in clinical research and biomedical applications for detecting diseases as it is considered as a sensitive and specific test that rarely provides a false positive test which had led to its popularity in detecting the diseases in the recent times.
However, in the recent clinical research studies; the researchers and scientists are working on better methods to improve the technique. Recent advancements in the field, such as Recombinant Immunoblotting Assay (RIBA) for detecting HCV and the usage of capillary electrophoresis are eliminating the need to use the western blotting technique. Thus, the advancement in substitute technologies acts as a restraining factor to the growth of the market.
The regions of North America, Europe, Latin America, Asia-Pacific and the Middle East and Africa form the global market for western blotting.
The APAC western blotting market is the fastest-growing market for western blotting, globally. The growth of the Asia-Pacific market region is attributable to the increasing prevalence of HIV AIDS in the region, coupled with the easy accessibility of resources. The increasing number of diagnostic centers to meet the testing needs of a large population of people with HIV/AIDS, especially in China, Indonesia and India, which account for 78% of new HIV infections, will drive the market growth in this region. Additionally, the augmented throughput screening in western blotting through automation has enabled numerous trials and researches in the region, which will boost the growth of the market in the forecast period.
The companies that have been mentioned in the market report are Rockland Immunochemicals, Inc., Lumigen, Inc., Roche Diagnostics, Roche Diagnostics International, Inc., PerkinElemer, Inc., Azure Biosystems, Inc., Advansta, Li-Cor, Inc., GE Healthcare, Cell Signaling Technology, Inc., Bio-Techne Corporation, Bio-Rad Technologies, Inc., Thermo Fisher Scientific, Inc., Merck KGaA and F. Hoffman La-Roche Ltd.
F. Hoffmann-La Roche, Ltd. is a Switzerland-based company focusing on healthcare research. The company develops innovative therapeutic & diagnostic products for testing blood and other body fluids & tissues. F. Hoffmann-La Roche is a multinational company operating in major regions of the world, such as North America, Europe, Latin America, Australia, Africa, Asia and Oceania.
The company reported revenues of (Swiss Francs) CHF 53,299 million for FY2017, with an increase of 5.4% over FY2016. KAPA Library Quantification Kits, KAPA HyperPlus Kits and Light Mix Modular Assays are some of the products that form a part of the company’s product portfolio. In January 2018, F. Hoffmann-La Roche, Ltd. launched VENTANA MMR IHC Panel to provide medical practitioners with an extensive group of IHC tests for patients diagnosed with colorectal cancer.
Key Topics Covered:
1. Global Western Blotting Market – Summary
2. Industry Outlook
2.1. Market Definition
2.2. Key Insights
2.2.1. Asia-Pacific Dominates the Overall Western Blotting Market
2.2.2. Growing Number of Applications For Western Blotting
2.2.3. Growing Acceptance of Digital Western Blotting
2.3. Porter’s Five Force Analysis
2.4. Market Attractiveness Index
2.5. Vendor Scorecard
2.6. Market Drivers
2.6.1. Growing Occurrence of HIV And Lyme Disease
2.6.2. High Demand For Proteomics
2.6.3. Rise in Applications For Western Blotting
2.7. Market Restraints
2.7.1. Advancements in Substitute Technologies
2.8. Market Opportunities
2.8.1. Industrialization of Western Blot Instruments
2.9. Market Challenges
2.9.1. Inflated Cost of Antibodies
2.9.2. Growing Research Initiatives And R&D Expenditure By Pharmaceutical And Biotechnology Companies
3. Western Blotting Market Outlook – By Product
3.1.1. Reagents And Buffers
3.1.3. Other Consumables
3.2.1. Gel Electrophoresis Instruments
3.2.2. Blotting Systems
220.127.116.11. Dry Blotting Systems
18.104.22.168. Semi-Dry Blotting Systems
22.214.171.124. Wet Blotting Systems
126.96.36.199. Chemiluminescent Imagers
188.8.131.52. Fluorescent Imagers
184.108.40.206. Other Imagers
4. Western Blotting Market Outlook – By Application
4.1. Biomedical & Biochemical Research
4.2. Disease Diagnostics
4.4. Other Applications
5. Western Blotting Market Outlook – By End-User
5.1. Research Institutes
5.2. Pharmaceutical & Biotechnology Companies
5.3. Diagnostic Centers
5.4. Other End-Users
6. Western Blotting Market – Regional Outlook
6.1. North America
6.1.1. Market By Product
6.1.2. Market By Application
6.1.3. Market By End-User
6.1.4. Country Analysis
220.127.116.11. United States
6.4. Latin America
6.5. Middle East And Africa
7. Competitive Landscape
7.1. F. Hoffman La-Roche Ltd.
7.2. Merck KGaA
7.3. Thermo Fisher Scientific, Inc.
7.4. Bio-Rad Technologies, Inc.
7.5. Bio-Techne Corporation
7.6. Cell Signaling Technology, Inc.
7.7. GE Healthcare
7.8. Li-Cor, Inc.
7.10. Azure Biosystems, Inc.
7.11. PerkinElemer, Inc.
7.12. Roche Diagnostics International, Inc.
7.13. Roche Diagnostics
7.14. Lumigen, Inc.
7.15. Rockland Immunochemicals, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/agr3h1
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900